YANG Jian,YANG Jian,WANG Chun-gang.Transfection of FHIT gene enhances the radiosensitivity of the human hepatocellular carcinoma cell line Hep G2[J].Chinese Journal of Radiological Medicine and Protection,2007,27(6):521-527
Transfection of FHIT gene enhances the radiosensitivity of the human hepatocellular carcinoma cell line Hep G2
Received:November 20, 2006  
DOI:
KeyWords:Ionizing radiation  Fragile histidine triad  Gene therapy
FundProject:国家自然科学基金资助项目(10575130)
Author NameAffiliationE-mail
YANG Jian Department of Radiation Medicine, Second Military Medical University, Shanghai 200433, China  
YANG Jian Department of Radiation Medicine, Second Military Medical University, Shanghai 200433, China  
WANG Chun-gang Department of Radiation Medicine, Second Military Medical University, Shanghai 200433, China  
高娴 Department of Radiation Medicine, Second Military Medical University, Shanghai 200433, China  
肖瑶 Department of Radiation Medicine, Second Military Medical University, Shanghai 200433, China  
韩玲 Department of Radiation Medicine, Second Military Medical University, Shanghai 200433, China linghan8888@yahoo.com.cn 
Hits: 2904
Download times: 1857
Abstract::
      Objective To evaluate the potential of the combination of fragile histidine triad (FHIT) gene therapy and radiation treatment.Methods A plasmid (pcDNA/FHIT) containing an open reading frame of FHIT gene was estabilished,and then the plasmid was transfected into a human hepatocellular carcinoma cell line (Hep G2). Using G418 for selection, a cell line (Hep G-2/FHIT) was generated which stably expressing FHIT gene. Using cell counting kit_8 and flow cytometry,the survival fraction, cell cycle and apoptosis of the Hep G-2/FHIT cells after exposure to 60Co γ-ray were measured.Results The transfection of FHIT gene enhanced the radiosensitivity of the Hep G-2 cell. The Hep G-2 cells without FHIT showed stronger G-2 checkpoint response, which indicated that enhanced radiosensitivity was due to the FHIT gene's role in the ATR/CHK 1 pathway.Conclusions Combining γ-rays with FHIT transfection might be an effective way to treat the radioresistant cancer and FHIT might be a potential gene target for tumor treatment.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9071703  On-line:0

v
Scan QR Code
&et=A4F29D64D5EE15DC8E7583DEDBB5D6E7391198CAD7118EC6A6770AE4321E27C17D466E7CE0839FD798BFF34EA0044D8EC0BB48C2BF7040C16E26BBFF837654DD436FB7F97B1E34D8722321A30919C3A268FC6C79572803CAAA90A55183E75B1C1B30CE61ACDA71AE9761FA787276CA23CC3400524772B8B7EB12F9081C65ED0A&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=A732AF04DDA03BB3&aid=EC0A322E35BCE651373067A845D79191&vid=&iid=B31275AF3241DB2D&sid=68FF5306A8F9C315&eid=F3549E0657848E2A&fileno=20070602&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="A732AF04DDA03BB3"; var my_aid="EC0A322E35BCE651373067A845D79191";